Seagen Inc. drugs

4 results

  • adcetris - brentuximab vedotin injection, powder, lyophilized, for solution

    (Brentuximab Vedotin)
    Seagen Inc.
    ADCETRIS treats classical Hodgkin lymphoma (untreated, consolidation, or relapsed), systemic and cutaneous anaplastic large cell lymphoma, CD30-expressing mycosis fungoides, peripheral T-cell lymphomas, and relapsed/refractory large B-cell lymphoma in adults; and high-risk cHL in pediatric patients 2 years and older.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • padcev ejfv - enfortumab vedotin injection, powder, lyophilized, for solution

    (Enfortumab Vedotin)
    Seagen Inc.
    PADCEV treats adult patients with muscle-invasive bladder cancer (MIBC) ineligible for cisplatin, combined with pembrolizumab as neoadjuvant/adjuvant therapy. Also indicated for locally advanced or metastatic urothelial cancer (mUC) in combination or as a single agent after prior treatment.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • tivdak - tisotumab vedotin injection, powder, for solution

    (Tisotumab Vedotin)
    Seagen Inc.
    TIVDAK treats adults with recurrent or metastatic cervical cancer whose disease has progressed on or after chemotherapy.
    Medication Details
    Drug Interactions

  • tukysa - tucatinib tablet

    (Tucatinib)
    Seagen Inc.
    Tukysa is used with trastuzumab and capecitabine for HER2-positive metastatic breast cancer (including brain metastases) in adults after prior anti-HER2 therapy. Also used with trastuzumab for RAS wild-type, HER2-positive metastatic colorectal cancer after prior chemotherapy.
    Medication Details
    Savings Programs
    1
    Drug Interactions